chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a pharmacist concerning a 21 week old male patient who on 01-SEP-2011 was vaccinated with his first dose of ROTATEQ (lot # not provided). No adverse experience had been reported. Whether the patient sought medical attention was not reported. Follow up information has been received from a physician concerning the patient with gastrooesophageal reflux disease (GERD) who at 12:00 pm on 01-SEP-2011 was vaccinated with the first dose of ROTATEQ (Lot number 669996/0326AA) and vaccinated IM with the first dose of PREVNAR 13 (Lot number: 037117) in left thigh, and the first dose of PENTACEL (Lot number: C3755AA) in right thigh. Concomitant therapy included PREVACID. The physician reported that no adverse event. The patient was fine before and after the vaccination. The physician also report that the patient was born weighted 9 pounds and 15.1 ounce. The patient had 2 siblings. Additional information is not expected.
This is a spontaneous report received from a contactable consumer or other non-HCP. A female patient, of unknown age, received the 2nd dose of BNT162B2 (Comirnaty, batch/lot# unknown), single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications not reported. Vaccination history included the 1st dose of BNT162B2 (Comirnaty), for COVID-19 immunization; and had a reaction(s): some confusion, speaking in a different language than which she normally spoke/speaking a different language, did not feel well for a few days, did not want to get out of bed for a few days and frequent urination 2-3 weeks. The patient reported back pain; pain in extremity/severe pain in her back and her leg, with outcome of unknown. Additional information: Other products was noted as not provided. The patient had severe pain in her back and her leg following her 2nd vaccine dose. Investigation assessment was noted as not provided. Reporter (daughter of the patient) stated she called the pharmacist to review the Pfizer vaccine ingredients. She was looking specifically for beef and anything that comes from a cow. Patient has anaphylactic reactions to anything that has beef. No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information expected.
9 days after shot I have extreme and debilitating arm pain.  I can?t move my arm up above my head and up to my side in alignment with my shoulder.  My bicep is working fine. Bilateral raises are very painful and difficult.  Today is Thursday and I have no improvement today
Patient awoke around midnight (as usual w/urge to urinate) and felt "paralyzed" and was too weak to get up. He wet the bed several times before regaining enough strength to get up and remained weak for 24 hours.
Shingles outbreak. Patient now taking Acyclovir 800mg five times daily for 10 days.
Body aches; CLAMMY; Joint aches; Chills; 100 degree Fever; This is a spontaneous report received from a contactable consumer, the patient. A 57-year-old non pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7534) via an unspecified route of administration in the right arm on 17Mar2021 at 10:00 (at the age of 57-year-old), as a single dose for COVID-19 Immunisation. Medical history included high BP (blood pressure) and obese. Concomitant medications were not reported. The patient did not have any allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Mar2021 at 13:00, the patient experienced 100-degree fever, chills, clammy, body and joint aches. No therapeutic measures were taken for the adverse events. The clinical outcome of the events 100-degree fever, chills, clammy, body aches and joint aches was recovering at the time of report.   No further follow-up attempts are needed. No further information is expected.
poop was red; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 12 year-old male patient received bnt162b2 (BNT162B2), administration date 13May2021 (Batch/Lot number: unknown) at the age of 12 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Smell metal" (unspecified if ongoing), notes: Caller also confirms this started two days ago, before receiving his vaccine. The patient's concomitant medications were not reported. The following information was reported: FAECES DISCOLOURED (non-serious), outcome "unknown", described as "poop was red".  Additional information: Caller states her son is 12 and he had the vaccine, the first dose, this morning and it was around 0900 and he came down about 20 minutes ago, he had gone to the bathroom and told her his poop was red and he could taste metal. Caller asking if Pfizer has seen these types of side effects, is this normal? Caller speaks to son when he confirms that the patient could smell metal, not taste it. Caller also confirms this started two days ago, before receiving his vaccine. Caller states well this makes her feel better. Caller states they can cancel it, she doesn't need to worry. Caller states she was kind of worried that she needed to get him checked out and now she will get him checked out but now she knows it's not related.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
severe allergic reaction; face was swollen; tongue hurts; sore throat; difficulty breathing; swelling of face/throat; fast heart beat; rash all over body; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 06Oct2021 (Batch/Lot number was not reported) as DOSE 3 (BOOSTER), SINGLE for covid-19 immunisation; influenza vaccine via an unspecified route of administration on 06Oct2021 (Batch/Lot number was not reported) as single dose for immunization.  The patient medical history and concomitant medications were not reported. She received the third shot of the Pfizer Covid 19 vaccine last Wednesday, 06Oct2021, the first dose, and she also had her flu shot; however, she experienced a severe allergic reaction. She wanted to know what needs to be done after experiencing this. It was still happening at the time of report. She stated she had been to the emergency room twice; she has spent about 4 hours there last night. She spent about 8 hours there and they have already told her there is nothing she can do. She noted she has been to the ER twice, received an epinephrine injection and was told that was all that could be done for her. Her face was swollen, tongue hurts, sore throat. She stated that she was experiencing almost every side effect on the list she is reading including severe ones. She experienced difficulty breathing, swelling of face/throat, fast heart beat and rash all over body. She explained she looked like a monster. The patient has not recovered from the events.  The lot number for BNT162B2 was not provided and will be requested during follow-up.
Information has been received form an emergency medical technician concerning a 4 year old female pt with no medical history reported, although it was noted that allergy not available at this time. On 01Jul03 the pt was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation). There were no concomitant medications. The vaccine was reconstituted with sterile saline instead of the required diluent. It was reported that the pt returned to the clinic on 02Jul03 with an injection site reaction that is red, edematous and painful. The emergency medical technician reported that the pt was being seen by the physician and treatment was not yet known. Additional information has been requested.
severe tinnitus and loss of hearing as some tones.  persistent since day after vaccination and continuing through time of reporting to VAERS.
eruptions on face, stomach, back, neck, groin, upper arm;pt reports that child is covered in pox;
Information has been received from a healthcare worker referring to an unspecified number of patients of unknown age and gender. The patients' concurrent conditions, concomitant medication and medical history were not provided. On 13-JUL-2015, unknown doses of oral, ROTATEQ were improperly exposed to 32F for 63 hours. Then, on unspecified dates since 13-JUL-2015, an unspecified number of patients may have received the improperly exposed oral, ROTATEQ (lot# K010224, expiration date 13-MAY-2016, dose unspecified). There were no known adverse effects. This is one of several reports received from the same source. Additional information has been requested.
3 1/2 hrs after receiving 2 vaccines, patient passed out in her home. Ambulance was called and she was transported to hospital. Spent 4 hrs in ER. CT Scan, Lab work- patient does not know lab results. Given an IV with "A Steroid in it" and med for nausea. Released.
pt recvd 2nd dose of vax & exp a recurrence of lightheadedness & dizziness; pt exp a euphoric sensation, tinnitus, ear fullness & earache; sx lasted for 6 wks & @ the time of the report pt had recovered;
Systemic: Fainting / Unresponsive-Medium, Additional Details: syncope
The patient did not exhibit any negative signs or symptoms related to the administration; Administration of an expired PNEUMOVAX 23 vaccine; This spontaneous report was received from a nurse practitioner and refers to a patient of unknown age or gender. The patient's concurrent and historical conditions, as well as concomitant medications were not reported.  On 07-OCT-2020, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) (dose, strength, route and anatomical location were not reported), lot # S026366 with expiration date of 17-SEP-2020 (expired product administered), for prophylaxis. It was reported that the patient did not exhibit any negative signs or symptoms related to the vaccination. combinationproductreport: Yes; brandname: PNEUMOVAX23 SYRINGE (DEVICE); commondevicename: Pneumococcal Vaccine, Polyvalent (23-valent); productcode: FMF; manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: S026366; expirationdate: 17-SEP-2020; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability.
Initial report was received from a health care professional on 06 September 2012. This is a cluster of four unidentified patients who had received FLUZONE INTRADERMAL, lot number UT4470AA and experienced anaphylactic reactions. A cluster of four unidentified patients had received FLUZONE INTRADERMAL, lot number UT4470AA (route, site and dates of administration not reported) and an unspecified amount of time later experienced anaphylactic reactions. They received "Epi" as corrective treatment and were taken to the emergency department for medical attention. Three of the patients had a history of allergies to several things, and two had asthma. No further information was available at the time of the report. The patients' outcomes were not reported. Documents held by sender: None.
Patient fully vaccinated in February, but required hospitalization due to breakthrough infection. Patient hospitalized 7/10-7/13 and then returned 7/14-7/17 due to lingering SOB. Dueing first hospitalization, she did not have respiratory complaints, but was originally brought in due to fall/weakness. During second hospitalization, she was treated with dexamethasone and required O2 supplementation.
Extreme breast pain to the point that I had to wear a high impact sports bra 24 hours a day for several weeks. After a breast ultrasound it was discovered that I had several cysts. After a follow up ultrasound 6 months later, all but one of the cysts was gone.
Vax given 19FEB91; rt knee swollen & painful & tender on 24FEB91; 2APR91 knee normal
Following the second phase around 5pm the intense feeling being extremely cold and despite being under 4 covers and a heated blanket I did not find relief. At this time the injection site was inflamed and painful to the slightest touch and beginning to experience a severe headache   I took Nyquil Cold and Flu 30mL and ibuprofen 800. 5am I am waking up with a fever of 101.7, stiff hands, and a continuation of the headache and body aches from the night. I again took ibuprofen 800, and 2 Tylenols extra strength (as needed) every 4 hours,  and Nyquil Cold and Flu 30mL in the morning and evening.  My body temperature seemed to have fluctuated every hour being unbearably cold to blood boiling hot with every move I make painful to the point of being bed ridden and needing assistance to get up to go to the restroom.  My injection site has grown from the size of a quarter on Friday Morning 1/22 to  about the size of grapefruit by Sunday 1/24 . I have pictures documenting its growth.
A week after getting the vaccine, I  went back to my routine of exercising about three times a week. When doing planks, I hear a hollow breathing as I am breathing myself.  It sounds like I have have another trachea that is making a separate sound. I exercise at home so there is no one around me and this never happened in my life.
Information has been received from a health professional concerning a 14 year old female with no pertinent medical history or drug reactions/allergies who in June 2007 was vaccinated with a first dose of GARDASIL 0.5 mL IM.  There was no concomitant medication.  On 04-APR-2008 the patient was vaccinated with a second dose of GARDASIL 0.5 mL IM.  The patient was at the physician's office when she experienced syncope and she remained there until she recovered and was able to leave.  Unspecified medical attention was sought at the physician's office.  On 04-APR-2008 the patient recovered.  No further information was available.  Additional information has been requested.
Woke up on 2/14/21 with full body rash, injection site redness, fever and diarrhea.   Rash described as itchy, generally distributed fine papules, improved with antihistamine.  Symptoms slightly improved after 4 days but still present.   Advised to contact PCP for evaluation
Had soreness/swelling/redness on the arm where injection was given for about 1-2 days. The symptom went away and reoccured on day 8 3/31/2021.
pt recv vax & sx reappeared as before; dx w/diabetes; seen by MD DEC92 for monthly estrogen shot & found to have petechiae & ecchymoses; exp rt abd pain, had abn liver function tests, inc glucose, bleeding gums, nose bleeds, insomnia, nervo
This spontaneous report was received from a physician, via a company representative, referring to a patient (Encounter key # 106174) of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 25-JUL-2016, the patient was vaccinated with a dose of RECOMBIVAX HB, "10Pk 5 mcg/0.5 mL SDLLokCap Ped", lot # L016959, expiration date: 12-MAR-2018, (dose number and route of administration were unknown), which was improperly stored. On unspecified dates, the RECOMBIVAX HB vaccine had three temperature excursions of 0.55 Celsius Degrees (33 Fahrenheit) for 96 hours, 1.11 Celsius Degrees (34 Fahrenheit) for 528 hours and -0.55 Celsius Degrees (31 Fahrenheit) for 72 hours, respectively. The vaccine status was reported as in excursion and the type of excursion and storage criteria were reported as refrigerator (R). No adverse effects were reported and no product quality complaint was involved. This is one of several cases from the same reporter. Additional information has been requested.
About a week after the vaccine, I started to notice a subtle difference in my heart beat.  At night, I could feel my heart beat was a little off. I went to the doctor for something unrelated and was place on EKG that's how the doctor detected my arrythmia.  He said I had A-fib and sent me to the ER.   The ER confirmed my A-fib with an EKG and prescribed Eliquis, furosemide and potassium.  A few days after discharge, I had chest heaviness and couldn't breath.  I went to the ER.  They did an EKG, CAT scan, blood work  which also confirmed A-fib and build up of fluid around my heart, lungs and abdomen.  I followed up with a cardiologist office and was to continue with the medications at discharge.    I am being followed with a cardiolgist.  Since then, my heart rythm is back to normal from what I can tell.
Left arm heaviness, numbness, painfulness and weakness unable to form a first with hand. Especially painful at arm pit and mid upper arm when the hand is is lifted. This occurrence started right after the first dose of the vaccine.  And has progressively worst since.
CELLULITIS, RIGHT UPPER ARM NEAR INJECTION SITE IS RED AND SWOLLEN STARTING AFTER ABOUT 24 HOURS POST INJECTION. PT ADVISED BY PCP AND PHARMACIST TO APPLY A COLD COMPRESS, TYLENOL AND ANTIHISTAMINE.
Muscle aches, fever to 103 degrees, flu like symptoms, headache, chills, night sweats, pain at injection site with bruising,  redness,itching, raised swelling right upper arm, tightness and warmth at redness,unable to raise arm to shoulder height without discomfort at  arm; some soreness at axillary lymph nodes bilateral arms
A 1 cm tender nodule was noted over the deltoid in the right arm, no erythema.
Patient came in to get Shingrix, Engerix, and Boostrix vaccinations on 7/2 in the AM. In the PM she called the pharmacy because she was experiencing a high fever of 102 F and muscle soreness in her left arm. It is uncertain what time she started experiencing the adverse events. She took Aleve per recommendation of the pharmacist and stated that it brought down her fever. Next day, 7/3, a call to the patient revealed her fever is gone, but her left arm is still very sore.
pt recv vax & w/in 5min devel intense urticarial response confined to entire lt leg;this resolved w/in 30min;
Within minutes of receiving the 1st dose of moderna, I got extremely shaky, weak, hot (started sweating), and felt as if I would pass out.  These symptoms mostly subsided within the 15 minute waiting period. The exhaustion/weakness lasted about 2-3 hours after the injection. I noticed upon eating afterwards (within 1 hour of vaccine) that it was harder to swallow and my throat just felt a little swollen.  By that evening, around 6 pm all of these symptoms had subsided and I just had a very sore arm (in the muscle) and tightness/swelling in my trapezius muscle for a few days.
pt recv vax 23OCT96 & 29OCT96 pt devel a varicella-like rash w/15 lesions mostly on back;over the next several days devel more than 200 lesions;presented to MD who felt pt had devel typical varicella;30OCT96 Tzanck smear revealed vari
Woke up aching all over,extre mely sore upper arm, temperature of 102.5, chills, vomited twice during the next 15 hours. Low grade temperature as late as Sunday afternoon. On Friday 10/24 I woke up to find my arm was very red down as far as the inside of the elbow, and injection area was still very sore. Redness spread the next day (10/25) to the underside of the arm with a large welt, still very sore  but starting to itch. Next day (10-/26) redness was starting to improve.  10/27 most of the redness is gone, but upper arm still itches.
lups (lips) tingling; Sick with fever; Itching all over; Severe reaction of extreme pain/aches/pains; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA ORAL (lups (lips) tingling), VACCINATION COMPLICATION (Sick with fever), PRURITUS (Itching all over), MYALGIA (severe reaction of extreme pain/aches/pains) and PYREXIA (Fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PARAESTHESIA ORAL (lups (lips) tingling), VACCINATION COMPLICATION (Sick with fever), PRURITUS (Itching all over), MYALGIA (severe reaction of extreme pain/aches/pains) and PYREXIA (Fever). At the time of the report, PARAESTHESIA ORAL (lups (lips) tingling), VACCINATION COMPLICATION (Sick with fever), PRURITUS (Itching all over), MYALGIA (severe reaction of extreme pain/aches/pains) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were reported. No treatment information was reported.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments    Reporter did not allow further contact
Erythema, swelling and tenderness right shoulder, upper 1/3, decreased ROM.
had soreness in the arm and stuff; had things like headache; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP and Physician). The reporter is the patient.  A 63 year-old female patient received bnt162b2 (BNT162B2), administration date 25Mar2021 (Lot number: ER8727) at the age of 63 years as dose 1, single and administration date 15Apr2021 (Lot number: EW0151) as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "had soreness in the arm and stuff"; HEADACHE (non-serious), outcome "unknown", described as "had things like headache".  Additional Information: Caller explained they both, her and her daughter, received both of the covid shots and had soreness in the arm and stuff, had things like headache. This was after the first two shots. Did any AE(s) require a visit to: Emergency Room: no; Physician Office: no. Prior Vaccinations (within 4 weeks) was reported as none.   No follow-up attempts are possible. No further information is expected.